Advocates say a new rule will make it harder for patients with conditions such as cancer and multiple sclerosis who rely on very expensive drugs to afford them.
A company is marketing a drug intended as a preventive for people at risk for heart disease with stunning statistics but has not yet released details of its study.
Greg Walden, Oregon's only Republican in Congress, was one of two lawmakers who received more than $200,000 from pharmaceutical companies since January 2017.